StreetAlpha
NovaBridge Biosciences · Earnings

NBP Earnings Results and History

Latest: quarter ended Dec 31, 2025From SEC 8-K, 10-Q and 10-K filingsNext report: Nov 12, 2026

NovaBridge Biosciences's earnings at a glance: the latest results and outlook from the press release, revenue, margins and EPS for every quarter from the company's SEC filings, and how the stock moved after each report. New results show here within about a minute of being filed.

← NBP stock page

Quarter ended Dec 31, 2025
From the 20-F/A
  • Revenue–
  • Net income−$30.8M
  • EPS (GAAP)–

Filed Jun 16, 2026. The next earnings release shows here within a minute of filing.

EPS beat rateFree accountlast 6 reports
Avg move afterFree accountnext day, after each report

Quarter by quarter

from 10-Q and 10-K filings
Quarter endedRevenueGrowthOp marginNet incomeEPSFree cash flow
Dec 2025–––−$30.8M––
Sep 2025–––−$6.8M––
Dec 2024–––−$10.8M––
Sep 2024–––−$20.5M––
Create a free account to see all 5 quarters, or sign in.

EPS here is GAAP diluted, as filed with the SEC. Estimates are usually based on adjusted EPS, so the two can differ. Growth compares with the same quarter a year earlier.

Reports and price reactions

last 7 reports
How NBP moved after each of its last 7 reports, the move options priced in, and StreetAlpha's call. Free account.Create free account

Year by year

fiscal years, from 10-K filings
Year endedRevenueGrowthOp marginNet incomeEPS
Dec 31, 2025–––−$46.3M–
Dec 31, 2024–––−$22.2M–
Dec 31, 2023–––−$207.7M–
Dec 31, 2022–––−$371.1M–
Dec 31, 2021–––−$365.9M–

Filings and dates

SEC EDGAR
  • Nov 12, 2026Next earnings reportexpected
  • Jun 16, 2026Quarterly report20-F/A All filings

Also see NBP institutional ownership and the earnings calendar.

NBP earnings FAQ

When is NBP's next earnings date?

NovaBridge Biosciences is expected to report on Nov 12, 2026. Dates can move until the company confirms them.

Is NBP's revenue growing?

In the quarter ended Dec 31, 2025 revenue was . The table on this page shows every quarter from the company's 10-Q and 10-K filings.

Where do these numbers come from?

Results, guidance and financials come from NovaBridge Biosciences's own SEC filings: the earnings press release (Form 8-K) and the quarterly and annual reports (10-Q and 10-K). Key takeaways summarize the press release. Estimates and price moves come from market data.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Results come from company filings with the SEC. Estimates are consensus figures from before each report. Key takeaways summarize the company's press release and may contain errors; the press release is the authoritative source.